Our conclusion corroborates observations of TCF7L2 associated gene regulatory impacts80 and studies reporting that TCF7L2 SNPs are associated with the presence of islet autoantibodies in LADA17, and autoantibody positivity in recent-onset T1D patients45. This evidence concerns the gene TCF7L2 and type 1 diabetes mellitus.